[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

YU45395A - Novo hemijsko jedinjenje, njegovo pripremanje i njegova primena kao leka - Google Patents

Novo hemijsko jedinjenje, njegovo pripremanje i njegova primena kao leka

Info

Publication number
YU45395A
YU45395A YU45395A YU45395A YU45395A YU 45395 A YU45395 A YU 45395A YU 45395 A YU45395 A YU 45395A YU 45395 A YU45395 A YU 45395A YU 45395 A YU45395 A YU 45395A
Authority
YU
Yugoslavia
Prior art keywords
medicine
preparation
application
new chemical
chemical unit
Prior art date
Application number
YU45395A
Other languages
English (en)
Inventor
R. Anderskewitz
K. Schromm
E-O Renth
F. Birke
A. Fugner
H. Hener
C. Meade
Original Assignee
Boehringer Ingelheim Kg.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Kg. filed Critical Boehringer Ingelheim Kg.
Publication of YU45395A publication Critical patent/YU45395A/sh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C257/00—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines
    • C07C257/10—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines
    • C07C257/18—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines having carbon atoms of amidino groups bound to carbon atoms of six-membered aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Psychiatry (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Novo jedinjenje može se pripremiti prema konvencijalnim postupcima i terapeutski upotrebiti kao antagonist LTB4 - receptora.
YU45395A 1994-07-13 1995-07-06 Novo hemijsko jedinjenje, njegovo pripremanje i njegova primena kao leka YU45395A (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4424714A DE4424714A1 (de) 1994-07-13 1994-07-13 Neue chemische Verbindung, ihre Herstellung und ihre Verwendung als Arnzneistoff

Publications (1)

Publication Number Publication Date
YU45395A true YU45395A (sh) 1997-12-05

Family

ID=6523048

Family Applications (1)

Application Number Title Priority Date Filing Date
YU45395A YU45395A (sh) 1994-07-13 1995-07-06 Novo hemijsko jedinjenje, njegovo pripremanje i njegova primena kao leka

Country Status (25)

Country Link
US (1) US5686496A (sh)
EP (1) EP0770058A1 (sh)
JP (1) JPH10502646A (sh)
KR (1) KR970704674A (sh)
CN (1) CN1152303A (sh)
AU (1) AU2736895A (sh)
BG (1) BG101104A (sh)
BR (1) BR9508395A (sh)
CA (1) CA2194886A1 (sh)
CO (1) CO4410185A1 (sh)
CZ (1) CZ8297A3 (sh)
DE (1) DE4424714A1 (sh)
EE (1) EE9700065A (sh)
FI (1) FI970095A0 (sh)
HR (1) HRP950363A2 (sh)
HU (1) HUT76827A (sh)
IL (1) IL114572A0 (sh)
MX (1) MX9700245A (sh)
NO (1) NO970123L (sh)
PE (1) PE35196A1 (sh)
PL (1) PL318114A1 (sh)
SK (1) SK1897A3 (sh)
WO (1) WO1996002496A1 (sh)
YU (1) YU45395A (sh)
ZA (1) ZA955781B (sh)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6191169B1 (en) 1992-08-28 2001-02-20 City Of Hope Human leukocyte 12-lipoxygenase and its role in the pathogenesis of disease states
US6486181B1 (en) 1992-08-28 2002-11-26 City Of Hope Human leukocutye 12-lipoxygenase and its role in the pathogenesis of disease states
AU5857296A (en) * 1995-05-17 1996-11-29 Eli Lilly And Company Use of leukotriene antagonists for alzheimer's disease
DE19546452A1 (de) * 1995-12-13 1997-06-19 Boehringer Ingelheim Kg Neue Phenylamidinderivate, Verfahren zu ihrer Herstelung und ihre Verwendung als Arzneimittel
DE19636689A1 (de) * 1996-09-10 1998-03-12 Boehringer Ingelheim Kg Neue Benzamidinderivate
DE19718334A1 (de) 1997-04-30 1998-11-05 Boehringer Ingelheim Pharma Neue Benzylaminderivate und Phenylethylaminderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
ID24720A (id) 1997-12-12 2000-08-03 Novartis Ag Senyawa amidino tersubstitusi dalam perawatan penyakit gangguan paru-paru kronis
DE19834713A1 (de) * 1998-07-31 2000-02-03 Boehringer Ingelheim Pharma Neue Phenylethylaminderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
US6528491B2 (en) * 2000-10-24 2003-03-04 Boehringer Ingelheim Pharma Kg Pyranoside derivatives
JP2004523512A (ja) * 2001-01-16 2004-08-05 ベーリンガー インゲルハイム ファルマ ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディトゲゼルシャフト ムチン遺伝子の増大された発現により生じる疾患の治療及び／又は予防のためのｌｔｂ４アンタゴニストの使用
US20040006092A1 (en) * 2001-08-31 2004-01-08 Neurochem, Inc. Amidine derivatives for treating amyloidosis
US20070105104A1 (en) * 2003-05-06 2007-05-10 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with g-protein-coupled receptor ltb4 (ltb4)
US7262223B2 (en) * 2004-01-23 2007-08-28 Neurochem (International) Limited Amidine derivatives for treating amyloidosis
AU2005260328B2 (en) * 2004-07-05 2009-10-01 Dong Wha Pharmaceutical Co., Ltd. Composition for the prevention and treatment of allergic inflammatory disease
CN102847155B (zh) * 2004-07-14 2014-04-16 炎症研究中心有限公司 抑制肿瘤转移的方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0518818A3 (en) * 1991-06-11 1993-04-28 Ciba-Geigy Ag Arylethers, their manufacture and use as medicament
SK281016B6 (sk) * 1992-02-05 2000-10-09 Boehringer Ingelheim Kg Amidínové deriváty, spôsob ich výroby, použitie a farmaceutické prostriedky s ich obsahom

Also Published As

Publication number Publication date
US5686496A (en) 1997-11-11
EE9700065A (et) 1997-08-15
EP0770058A1 (de) 1997-05-02
JPH10502646A (ja) 1998-03-10
DE4424714A1 (de) 1996-01-18
BG101104A (en) 1998-04-30
KR970704674A (ko) 1997-09-06
FI970095A (fi) 1997-01-10
NO970123D0 (no) 1997-01-10
FI970095A0 (fi) 1997-01-10
MX9700245A (es) 1997-05-31
CN1152303A (zh) 1997-06-18
HRP950363A2 (en) 1997-08-31
ZA955781B (en) 1996-02-22
CZ8297A3 (en) 1997-09-17
SK1897A3 (en) 1997-08-06
WO1996002496A1 (de) 1996-02-01
BR9508395A (pt) 1997-12-23
CA2194886A1 (en) 1996-02-01
AU2736895A (en) 1996-02-16
HU9700060D0 (en) 1997-02-28
IL114572A0 (en) 1995-11-27
HUT76827A (en) 1997-11-28
CO4410185A1 (es) 1997-01-09
NO970123L (no) 1997-01-10
PE35196A1 (es) 1996-09-05
PL318114A1 (en) 1997-05-12

Similar Documents

Publication Publication Date Title
YU45395A (sh) Novo hemijsko jedinjenje, njegovo pripremanje i njegova primena kao leka
PT1109812E (pt) Pirrolobenzodiazepinas
SE9801992D0 (sv) New 3-aryl-2-hydroxypropionic acid derivative I
UA66750C2 (en) Substituted 1-phenylpirazole 3-carboxamides, a method for the preparation thereof and intermediary compounds, pharmaceutical composition having affinity to neurotensin receptors
NO20053106D0 (no) Oral, analgesisk doseringsform med forlenget frigivelse.
RS51157B (sr) Baff receptor (bcma), imunoregulatorni agens
DK0742715T3 (da) Orale, væskeformige præparater indeholdende paroxetin-resinat
NO965516D0 (no) Sterolderivater anvendt til regulering av meiose
MX9700273A (es) Benzamidinas sustituidas, su preparacion y empleo como sustancias medicamentosas.
IT1285770B1 (it) Composti corticoidei
ES2160410T3 (es) Preparados de complejos de protrombina inmunotolerantes.
NL193957B (nl) Pijpleidingverbinding, alsmede verbindingsstuk.
ES2166806T3 (es) Preparaciones adhesivas analgesicas antiinflamatorias.
SE8904298D0 (sv) New compounds
UY26085A1 (es) N-[-(4-aminofenil)-2,3-dihidro-1,4-benzodioxina-2-metanamina su preparacion y su aplicacion en terapeutica
SE9504662D0 (sv) New compounds
WO1998038994A3 (de) Kombinationspräparat aus 2-methylthiazolidin-2,4-dicarbonsäure und paracetamol
CA2362697A1 (en) Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-10-ols, method for producing them and their use as medicaments
BR9606955A (pt) Heterocicloalquenos substituísos
TR200000154T2 (tr) 2,4,4-Trisübstitüe-1,3-Dioksolan mantar önleyiciler.
DE69614552D1 (de) MODIFIZIERTE ALPHA-D-GLCP-(1,2)-ALPHA-D-Glcp-(1,3)-ALPHA-D-Glcp-ANALOGE
AU1022201A (en) Novel LTB4 antagonist, method for the production thereof and its use as a medicament
IT213227Z2 (it) Anello di fissaggio,in particolareper giunti di tubazioni
SE9900693D0 (sv) Novel process
ECSP951476A (es) Benzamidinas sustituidas, su preparacion y empleo como sustancias medicamentosas